If you are having trouble viewing this page, please click here
Kenneth Aldrich, International Stem Cell Corporation's CEO and Chairman, to Present Webcast at the Stem Cell Summit, May 12, 2009.
The Stem Cell Summit will host numerous state and country webcast presentations showcasing their research and investment in this burgeoning field, along with displays by leading companies and institutions all contributing to this growth.
Title: Beyond Embryonic Stem Cells
Presenter: Kenneth Aldrich, ISCO CEO & Chairman
Date: Tuesday, May 12, 2009
Scheduled Time: 9:00 – 9:45 a.m. Pacific Time
Link to register for the free webcast: http://www.brighttalk.com/webcasts/3928/attend.
With the announcement of a pending change in federal rules governing stem cell research, embryonic stem cells have dominated the news in recent days. However, there are other methods of producing pluripotent stem cells that provide exciting alternatives and opportunities to advance human therapy that go beyond what is likely from embryonic stem cells. These include Parthenogenic Stems Cells (made without the use or destruction of human embryos) that may offer a solution to the problem of immune rejection; Induced Pluripotent Stem Cells made from skin or other tissue, including possibly tissue from the patient; and Somatic Cell Nuclear Transfer, which has been largely forgotten, but offers very interesting possibilities. This presentation will discuss these various methods and their advantages and disadvantages as compared to each other and embryonic stem cells. To register (by setting up a free account) for the webcast please click on the following link:
The webcast is free for registered participants and can be viewed live or later on-demand.